Latest Insider Transactions at Inotiv, Inc. (NOTV)
This section provides a real-time view of insider transactions for Inotiv, Inc. (NOTV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inotiv, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inotiv, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2021
|
John Gregory Beattie Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
440
+1.7%
|
-
|
|
May 07
2021
|
Joseph Earl Flynn Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
880
+0.68%
|
-
|
|
May 07
2021
|
William D Pitchford Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
880
+2.13%
|
-
|
|
May 07
2021
|
John E Sagartz Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
880
+0.14%
|
-
|
|
May 07
2021
|
Robert Leasure Jr. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,667
+1.57%
|
-
|
|
May 07
2021
|
Beth Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
880
+2.44%
|
-
|
|
Apr 01
2021
|
Gregory Cole Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,683
+7.59%
|
-
|
|
Apr 01
2021
|
R Matthew Neff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,683
+4.21%
|
-
|
|
Apr 01
2021
|
Richard Allen Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,683
+5.91%
|
-
|
|
Mar 05
2021
|
Beth Taylor Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+12.72%
|
$85,000
$17.7 P/Share
|
|
Mar 01
2021
|
John Gregory Beattie Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
1,712
+6.41%
|
$30,816
$18.6 P/Share
|
|
Feb 24
2021
|
Robert Leasure Jr. President and CEO |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$70,000
$14.42 P/Share
|
|
Feb 23
2021
|
John Gregory Beattie Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
8,288
+26.25%
|
$116,032
$14.0 P/Share
|
|
Feb 15
2021
|
John Gregory Beattie Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Dec 29
2020
|
Robert Leasure Jr. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+15.01%
|
-
|
|
Dec 02
2020
|
John E Sagartz Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,653
+1.48%
|
-
|
|
Dec 02
2020
|
Michael Baim VP Bioanalytical Services |
BUY
Grant, award, or other acquisition
|
Direct |
6,938
+32.13%
|
-
|
|
Dec 02
2020
|
William D Pitchford Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,541
+16.02%
|
-
|
|
Dec 02
2020
|
Beth Taylor Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,995
+16.99%
|
-
|
|
Dec 02
2020
|
Philip A Downing Sr. VP, Preclinical Srvcs. |
BUY
Grant, award, or other acquisition
|
Direct |
7,964
+15.89%
|
-
|
|
Jun 07
2019
|
Robert Leasure Jr. President and CEO |
BUY
Open market or private purchase
|
Indirect |
7,500
+6.67%
|
$7,500
$1.98 P/Share
|